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Abstract
Background: Nasopharyngeal carcinoma (NPC) is a common malignancy in Southern China and Southeast Asia. In
this study, we investigated the functional and molecular mechanisms by which CDC42-interacting protein 4 (CIP4)
influences NPC.
Methods: The expression levels of CIP4 were examined by Western blot, qRT-PCR or IHC. MTT assay was used to
detect the proliferative rate of NPC cells. The invasive abilities were examined by matrigel and transwell assay. The
metastatic abilities of NPC cells were revealed in BALB/c nude mice.
Results: We report that CIP4 is required for NPC cell motility and invasion. CIP4 promotes the activation of N-WASP
that controls invadopodia formation and activates EGFR signaling, which induces downstream MMP2 (matrix
metalloproteinase 2) upregulation. In addition, CIP4 could promote NPC metastasis by activating the EGFR pathway.
In nude mouse models, distant metastasis was significantly inhibited in CIP4-silenced groups. High CIP4 expression
is an independent adverse prognostic factor of overall survival (OS) and distant metastasis-free survival (DMFS).
Conclusion: We identify the critical role of CIP4 in metastasis of NPC which suggest that CIP4 may be a potential
therapeutic target of NPC patients.
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Background
Nasopharyngeal carcinoma (NPC) is one of the most
common malignancies in southern China and Southeast
Asia [1, 2]. The standard treatment modality for NPC is
radiotherapy and platinum-based chemotherapy [3–5].
Significant improvements in therapeutic efficacy have
been achieved with the extensive application of
intensity-modulated radiotherapy (IMRT) together with
concurrent chemotherapy [6, 7]. Distant metastasis is
the main reason of treatment failure [8]. However, the
molecular mechanisms underlying NPC metastasis
remain poorly understood.
Metastasis is a complex series of steps in which cancer
cells leave the original tumor and spread to other organs
via the bloodstream, lymphatic system, or body cavities
[9]. To move toward other organs, cancer cells must
extend their plasma membrane forward at the front,
forming the leading edge of the cell. Cells extend four
different plasma membrane protrusions at the leading
edge: lamellipodia, filopodia, podosomes and invadopo-
dia [10–12]. These structures uniquely contribute to
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cellular motility depending on specific circumstances
[12]. Invadopodia are protrusions that allow focal deg-
radation of the extracellular matrix to facilitate invasion
through the tissues. Invadopodium extension in three
dimensions (3D) requires force driven by actin
polymerization. Demonstration of invadopodia is typic-
ally performed on two-dimensional (2D) surfaces coated
with extracellular matrix proteins, where the invadopo-
dia are present on the ventral surface [13–15]. Invadopo-
dia degrade the extracellular matrix and require the
delivery of vesicles containing matrix-degrading
proteases, particularly membrane type 1 metalloprotease
(MT1-MMP) from the cellular plasma to invadopodial
tip. These vesicles are targeted to invadopodia by the
vesicle-tethering exocyst complex [16].
In mammals, the TOCA family (also named F-BAR
proteins) includes three members: TOCA-1 (Transducer
of CDC42-dependent actin assembly), CIP4 (CDC42-
interacting protein 4), and FBP17 (formin-binding pro-
tein 17). CIP4 is implicated in clathrin-mediated endo-
cytosis (CME), during which it senses and promotes
membrane curvature through its F-BAR domain and
binds to key regulators of actin dynamics (e.g., the
nucleation promoting factor N-WASP) and endocytosis
(e.g., dynamin) through their SH3 domain [17, 18].
Furthermore, CIP4 acts as an effector of the small
GTPase CDC42 that promotes cell migration in breast
cancer [19, 20].
Here, we demonstrate that by regulating invadopodia
formation, assembly and extracellular matrix (ECM)
degradation, CIP4 controls cell migration and invasion
in response to EGFR signaling. We further demonstrate
that CIP4 knock-down (KD) had no overt effect on
tumor growth, but impaired the ability of distant metas-
tasis in mouse xenograft models. Consistently, CIP4
expression is increased in NPC compared with nasopha-
ryngeal mucosa. Evaluating the expression of CIP4 in
primary tumors from 169 NPCs also revealed that high
CIP4 protein levels correlate with worse overall survival
(OS) and distant metastasis-free survival (DMFS) in
NPC patients.
Methods
Cell culture, cellular growth curve, and colony-formation
assays
The human nasopharyngeal carcinoma cell lines 5-8F and
S18 were maintained in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS at 37 °C and 5% CO2.
Cellular growth curves were plotted by using the cellu-
lar viability values assessed by the MTT method (Cell
Titer 96 Aqueous One Solution Cell Proliferation Assay
solution; Sigma). Briefly, 1000 cells/200 μl of medium
were seeded into a 96-well plate (Corning) and cultured
under normal conditions. At various time points after
seeding, the cells in each well were stained with MTT
(Sigma, M2128) for 3 h. Then, medium was discarded,
and 200 μl of DMSO was added to each well and
incubated for 10 min, and the OD490 was determined
with a microplate reader.
For the colony-formation assays, 500 cells/2 ml were
seeded into a 6-well plate (Corning). After 10 days, the
cells were washed with phosphate-buffered saline (PBS),
fixed with methanol for 15 min at room temperature,
and stained with 1% crystal violet for 20 min. The
colonies were counted. All experiments were independ-
ently repeated at least three times.
RNA isolation and real-time quantitative reverse-
transcription PCR (qPCR)
Total RNA was extracted from cultured cell lines using
TRIzol reagent (Invitrogen) and subjected to reverse
transcription using a cDNA Synthesis Kit (Thermo,
K1622). Real-time qPCR was performed using a SYBR
FAST Universal qPCR Kit (KAPA, KK4602). The relative
expression levels of the target genes were calculated as
two power values of ΔCt (the Ct of GAPDH or CIP4
minus the Ct of the target gene). The sequences of the
PCR primers used for amplification were as follows:
GAPDH forward, 5′- GTCTCCTCTGACTTCAACA
GCG -3′;
GAPDH reverse, 5′- ACCACCCTGTTGCTGTAGC
CAA -3′;
CIP4 forward, 5′- CGAATATGCGGCTCAACTGCA
G -3′;
CIP4 reverse, 5′- CCTGCGTTCATCCATGTCTTGG
-3′.
Small interfering RNA transfection
The negative control small interfering RNA (NC) was
purchased from RIBOBIO, and siRNA sequences target-
ing human CIP4 are 5′- GCATGAAGGTGGCTG
CAAA-3′(si#1) and 5′- CCGAAGTGGAACAGGCTTA
-3′(si#2). Transient transfections of NPC cells were per-
formed as described previously using the Lipofectamine
RNAiMAX Reagent (Invitrogen) protocol. Briefly, 60
pmol siRNA was mixed with Opti-MEM Medium
(Invitrogen) and incubated at room temperature for
15 min. Then, the mixture was added to the cells.
Lentiviral transduction studies
Cell lines stably expressing CIP4 short hairpin RNA
(shRNA) or a negative control shRNA were purchased
from FulenGen Co. Ltd. (Guangzhou, China). Lentivi-
ruses were produced by 293T cells with one of the
shRNA using X-tremeGENE DNA transfection reagents
(Roche). Infectious lentiviruses were harvested 48 h after
transfection and filtered through 0.45 mm filter
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(Millipore, Bedford, MA). Cells were transduced with
lentiviruses CIP4 shRNA or negative control shRNA and
then cultured in medium containing 2 mg/ml puromycin
(Sigma) for 3 days for selection. CIP4 knockdown
efficiency was determined by immunoblotting.
Immunoblotting
Immunoblotting was performed using the standard
protocol. The primary antibodies, including rabbit anti-
human CIP4 polyclonal antibody (Proteintech), rabbit
anti-human N-WASP polyclonal antibody (Proteintech),
rabbit anti-human phospho-N-WASP polyclonal anti-
body (Abcam), rabbit anti-human MMP2 polyclonal
antibody (Cell Signaling Technology), rabbit anti-human
MMP9 polyclonal antibody (Cell Signaling Technology),
rabbit anti-human ERK1/2 polyclonal antibody (Cell Sig-
naling Technology), rabbit anti-human phospho-ERK
polyclonal antibody (Cell Signaling Technology), rabbit
anti-human EGFR polyclonal antibody (Cell Signaling
Technology), rabbit anti-human phosphor-EGFR
polyclonal antibody (Cell Signaling Technology), rabbit
anti-human AKT1 polyclonal antibody (Cell Signaling
Technology), rabbit anti-human phospho-AKT
polyclonal antibody (Cell Signaling Technology) and
β-actin polyclonal antibody (Cell Signaling Technology)
were used at a dilution of 1:1000.
ECM degradation assay
For ECM degradation assay, glass-bottom dishes were
coated with Gelatin From Pig Skin, Oregon Green® 488
Conjugate (Invitrogen) and then treated with 0.5% glu-
taraldehyde as described earlier [21–23]. Cells were
cultured on these glass-bottom dishes in DMEM, fixed
and stained with anti-cortactin antibody or Rhodamine
Phalloidin (Cytoskeleton). Fluorescent images were
obtained using a laser scanning confocal imaging system
(OLYMPUS FV1000). Cells in which dot-like degrad-
ation of Alexa-gelatin was observed were judged as
positive for invadopodia.
Migration and invasion assays
Migration assays were conducted with Biocoat without
Matrigel (Corning. Life sciences), and invasion assays were
performed with Biocoat with Matrigel (Corning. Life
sciences) following the manufacturer’s instructions. The
harvested Biocoats were then stained with crystal violet,
and invaded cells were counted under a microscope. Both
experiments were repeated independently three times.
Animal experiments
Female athymic mice (Beijing Charles River Laboratory
Animal Center) were purchased at 4–5-weeks-of-age
and maintained under a specific pathogen-free environ-
ment. All animal experiments were approved by the
Institutional Animal Care and Use Committee of the
Sun Yat-Sen University Cancer Center.
For the tumor xenograft experiments, the tumor cells
(1 × 106 cells/tumor in 100 μl DMEM) were intraven-
ously injected through the tail vein of mice. Distant me-
tastases in lungs were assessed and counted after
5 weeks when mice were sacrificed. Lungs and livers
were excised and embedded in paraffin for further study.
The spontaneous lymph node (LN) metastasis experi-
ments were conducted as previously reported [24–26].
Briefly, 2 × 105 cells in 20 μl DMEM were subcutane-
ously injected into the footpad of the left hind limb of
each mouse to generate a primary tumor. After 4 weeks,
the experiments were terminated, and the popliteal LNs
of the left hind feet were isolated and preserved in RNA-
later solution (Invitrogen). The primary tumor weight
was measured and calculated by subtracting the weight
of the contralateral foot without the tumor from the
weight of the foot carrying the tumor. LNs were homog-
enized in TRIzol for total RNA extraction using the
Bullet Blender (Next Advance). Reverse transcription
and real-time PCR were performed to assess metastasis
using specific primers for human HPRT, which do not
cross-react with the corresponding mouse gene [27].





ACTB (universal for human and mouse) forward:
5′-CAATGAGCTG CGTGTGGC-3′;
ACTB (universal for human and mouse) reverse:
5′-CGTACATGGC TGGGGTGTT-3′.
Human tissue samples
To compare the mRNA expression levels of CIP4 among
different stages of NPC development, 19 non-cancerous
nasopharyngeal mucosa and 15 primary NPCs were
obtained at the Department of Nasopharyngeal Carcin-
oma, Sun Yat-sen University Cancer Center (SYSUCC).
In total, 169 formalin-fixed and paraffin-embedded NPC
specimens were obtained from patients at SYSUCC
pathologically diagnosed between February 2006 and
December 2009. The 169 cases of NPC with sufficient
follow-up data qualified for analyses after immuno-
histochemical (IHC) staining for CIP4. All human tissue
samples were obtained with patient consent and the
approval of the Institutional Clinical Ethics Review
Board at SYSUCC.
In IHC analysis of CIP4, the paraffin-embedded slices
were deparaffinized, rehydrated, and blocked in 5%
bovine serum albumin (BSA) at room temperature for
20 min. The samples were incubated with rabbit
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polyclonal antibody against CIP4 (ab108313, Abcam) at
a dilution of 1:100 at 4 °C overnight followed by horse-
radish peroxidase (HRP) anti-rabbit immunoglobulin at
a concentration of 1:100 for 30 min at 37 °C. The pri-
mary antibodies were detected with 3, 3-diaminobenzi-
dine substrate visualization and counterstaining with
hematoxylin (GTVision III Detection System/Mo & Rb).
For each tumor, we determined a proportion score and
an intensity score. Cytoplasmic and membranous stain-
ing intensity were categorized as follows: absent staining
as 0, weak as 1, moderate as 2, and strong as 3. The per-
centage of stained cells was categorized as no staining =
0, 1–10% of stained cells = 1, 11–50% = 2, 51–80% = 3,
and 81–100% = 4. The proportion and intensity were
then multiplied to produce a total score ranging from 0
to 12. The median score of CIP4 (score = 4) was used as
the cutoff value to divide the patients into the high (>
median) and low (≤ median) CIP4 expression groups.
Statistical analysis
Student’s t-test was used to compare two independent
groups of data. The median IHC staining score was used as
a cut-off value to divide the patients into low and high CIP4
expression groups. Chi-squared tests were applied to analyze
the relationship between CIP4 expression and clinicopatho-
logical status. The significance of several variables for
survival was analyzed using the Cox regression model
in a multivariate analysis. P-value < 0.05 was consid-
ered statistically significant in all cases.
Results
CIP4 is highly expressed in NPC tissues and is associated
with poor prognosis
To investigate the underlying clinical significance of
CIP4, the CIP4 expression level with clinicopathological
features in 169 NPCs (informative IHC cases) was ana-
lyzed (Fig. 1a). High CIP4 expression was significantly
associated with M stage and prognosis (Table 1).
Fig. 1 High CIP4 expression correlates with shorter overall survival and distant-metastasis-free survival in NPC patients. a Levels of CIP4 protein expression
in NPC tissues are shown under high magnifications microscopy. b Kaplan-Meier analysis indicates upregulation of CIP4 was significantly associated with
poorer overall survival and distant metastasis-free survival of NPC patients (p= 0.0053, p= 0.0310, respectively). c CIP4 mRNA expression in the NPC tissues
and non-cancerous nasopharyngeal (NP) mucosa tissues detected by qPCR
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Multivariate analyses of different prognostic parameters
revealed that high CIP4 expression was an independent,
unfavorable prognostic indicator for OS and DMFS
(Table 2). In the Kaplan-Meier analysis, OS and DMFS
were increased for patients with low CIP4 expression
compared with those with high CIP4 expression (Fig. 1b).
CIP4 mRNA levels were also increased in NPC tissues
compared with nasopharyngeal mucosa (Fig. 1c). These
data collectively demonstrate a close correlation between
CIP4 expression level and poor patient outcomes, imply-
ing an important role for CIP4 in NPC progression.
Knocking-down CIP4 inhibits the migration and invasion
of highly metastatic NPC cells without influencing general
cell growth or contact-independent cell growth
To further confirm whether CIP4 influences cell mobil-
ity in migration and invasion without affecting tumor
formation, CIP4 was knocked down in two highly meta-
static cell lines (5-8F and S18) via RNA interference
(RNAi) with two shRNAs targeting CIP4 (CIP4-KD1 and
CIP4- KD2). A scramble shRNA was used as a control
(CIP4-CON). Western blotting revealed a significant
reduction in CIP4 protein levels (Fig. 2a).
Functional assays of cell growth curves and colony for-
mation revealed that the NPC cell growth rate and
contact-independent cell growth were not significantly
altered in CIP4 KD cells compared with control cells
(Fig. 2b, c and d).
CIP4 promotes NPC cell migration and invasion in vitro
To examine the causal role of CIP4 in NPC cell motility,
we used migration assays to evaluate cell migration in
CIP4 control and KD cells. CIP4-KD cells exhibited
reduced migration compared with controls (Fig. 3a and
c). Next, we compared the effects of CIP4-KD on the in-
vasive potential of 5-8F and S18 cells using Matrigel-
Table 1 Association between expression of CIP4 and
clinicopathological characteristics in 169 NPC patients
Clinical factor Cases
(n = 169)
CIP4 expression P value
High Low
(n = 83) (n = 86)
Gender
Male 128 63 65 0.961
Female 41 20 21
Ages (years)
< 45 79 39 40 0.951
≥ 45 90 44 46
T stage
T1-2 49 22 27 0.484
T3-4 120 61 59
N stage
N0-1 89 41 48 0.404
N2-3 80 42 38
M stage
M0 160 75 85 0.035
M1 9 8 1
Clinical stage
I-II 17 6 11 0.229
III-IV 152 77 75
WHO histological classification Type 2
Differentiated 8 2 6 0.300
Undifferentiated 161 81 80
Local-regional relapse
No 166 81 85 0.975
Yes 3 2 1
Distant metastasis
No 156 73 83 0.072
Yes 13 10 3
Progression
No 147 66 81 0.005
Yes 22 17 5
Death
No 142 63 79 0.005
Yes 27 20 7
Statistical significance (p < 0.05) is shown in bold and italic
Table 2 Univariate and multivariate analyses of different
prognostic parameters in NPC patients
Variables Univariate analysis Multivariate analysis
HR Cl P HR Cl P
OS
Gender 2.763 0.832–9.181 0.097 … … …
Age 2.841 1.198–6.734 0.018 5.148 1.933–13.707 0.001
T stage 1.317 0.554–3.129 0.533 … … …
N stage 1.745 0.810–3.761 0.155 … … …
M stage 9.441 3.769–23.647 <0.001 14.195 4.642–43.407 <0.001
Clinical stage
24.271 0.134–4382.908 0.229 … … …
CIP4 1.137 1.043–1.240 0.004 1.111 1.015–1.216 0.022
DMFS
Gender 4.019 0.523–30.911 0.181 … … …
Age 1.451 0.475–4.436 0.514 … … …
T stage 0.666 0.218–2.037 0.476 … … …
N stage 1.908 0.624–5.832 0.257 … … …
M stage 13.355 4.058–43.955 <0.001 8.565 2.495–29.401 0.001
Clinical stage
23.874 0.011–53961.801 0.421 … … …
CIP4 1.199 1.046–1.374 0.009 1.159 1.006–1.336 0.041
Abbreviations: OS overall survival, DMFS distant metastasis-free survival, CI confidence
interval, HR hazard ratio. Statistical significance (p<0.05) is shown in bold and italic
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coated transwell chambers. Interestingly, both 5-8F and S18
KD cells exhibited severe defects in cell invasion compared
with their respective controls (Fig. 3b and d). Together,
these results suggest that CIP4 is a positive regulator of
NPC cell migration and invasion through the ECM.
CIP4 regulates invadopodia assembly through activation
of N-WASP
The Arp2/3 complex and neural Wiskott–Aldrich syn-
drome protein (N-WASP; encoded by WASL) are essen-
tial components of invadopodia, which regulate actin
polymerization in the early phase of invadopodium as-
sembly [28]. Lorenz and colleagues previously measured
and directly imaged N-WASP activity in vivo by using
FRET microscopy and observed that N-WASP was in-
volved in the cytoskeleton reorganization of invadopodia
of migrating carcinoma cells. N-WASP can be activated
by many upstream factors, including Cdc42, PIP2, or
phosphorylation, and it is likely that different cell
responses are regulated by different upstream activators
[29]. Because CDC42 interacts with N-WASP and facili-
tates the nuclear translocation of EGFR [30], we investi-
gated the role of CIP4 EGF-induced N-WASP activation.
N-WASP phosphorylation was decreased in CIP4-
silenced cells compared with control cells (Fig. 4a).
Previous research showed a rapid, transient increase in
acceptor photobleaching fluorescence resonance energy
transfer (apFRET) efficiency between CIP4 and N-WASP
after EGF stimulation in the fluorescence resonance en-
ergy transfer assay [20]. In the presence of EGF, control
5-8F cells increased the phosphorylation of N-WASP at
1 min (Fig. 4b). Knockdown of CIP4 decreased the basal
level of N-WASP phosphorylation in 5-8F cells (Fig. 4c).
These results suggest that CIP4 significantly altered
Fig. 2 Suppression of CIP4 expression has no effect on growth in NPC cells in vitro. a Decreased expressions of CIP4 were respectively confirmed
by Western blotting in CIP4-silenced 5-8F and S18 cells compared with scrambled shRNA control cells. b Cell growth rates between CIP4-silenced
and scrambled shRNA control cells were compared by MTT assay. c and d The colony formation assays were performed to determine the effect
of growth in CIP4 knockdown and control cells. N.S. means no significance. The data are presented as the mean ± S.D. (from triplicates)
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invadopodia assembly by affecting the level of activated
N-WASP.
CIP4 has important functions in invadopodia formation
and ECM degradation
N-WASP is an actin-regulatory protein associated with
invadopodium markers, including ARP2/3 and cortactin.
These proteins then form a complex with the small
GTPase CDC42 [31]. To determine whether CIP4 played
an important role in invadopodia formation, NPC cells
were plated on glass-bottom dishes of Oregon Green®
488 Conjugate-labeled gelatin and incubated overnight
to allow invadopodia formation. As shown in Fig. 5a and
b, the formation of invadopodia was visualized by co-
immunostaining cells for filamentous actin (F-actin)
using fluorescently conjugated phalloidin (red) and
invadopodium-associated protein cortactin (blue). Dot-
like ECM degradation (loss of green color) under the cell
was also observed (see arrowhead).
To examine the role of CIP4 in invadopodia formation
by NPC cells, we quantified the percentage of cells with
invadopodia and the distribution of the number of inva-
dopodia per cell after treatment knockdown with control
or CIP4 siRNA. We observed a significantly reduced
percentage of cells with invadopodia and fewer invado-
podia per cell in CIP4-siRNA-treated cells. To evaluate
the size and function of invadopodia, we quantified the
area of gelatin degradation per cell and found signifi-
cantly less gelatin degradation after CIP4 silencing
(Fig. 5c and d).
CIP4 regulates EGFR signaling and promotes MMP-2 expres-
sion in NPC cells
TOCA family members control early events of epider-
mal growth factor receptor (EGFR) clathrin-mediated
Fig. 3 Suppression of CIP4 expression inhibits the migration and invasion of highly metastatic NPC cells in vitro. a and c Silencing CIP4 could inhibit
cell migration and cell invasion in 5-8F and S18 cells compared with scrambled shRNA control cells. b and d Columns, average of three independent
experiments; Bars, S.D. ***P < 0.001
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endocytosis (CME) and trafficking [17, 32], and EGFR is
widely expressed in NPC [33]. To assess the effects of
CIP4 on EGFR signaling in NPC cells, we performed a
20-min time course of EGF treatment. EGF treatment of
CIP4 CON and KD cells led to rapid phosphorylation of
EGFR (pEGFR; Y1068) that was sustained throughout
the time course. CIP4 KD cells exhibited no overt
defects in EGF-induced pEGFR levels compared with
control cells (Fig. 6a and b).
To address whether CIP4 regulates EGFR signaling to
downstream pathways, we profiled EGF-induced phos-
phorylation of the activation loop sites (S473) in Akt
(pAkt) and Erk kinases (pErk) in CIP4 CON and KD
cells. EGF-induced phosphorylation of Akt (S473) did
not differ in CIP4 CON and KD cells (Fig. 6c and d). In
contrast, CIP4 KD resulted in a less sustained phosphor-
ylation of Erk with EGF treatment (Fig. 6e).
The maturation process for invadopodia involves the
recruitment and activation of multiple pericellular prote-
ases that facilitate ECM degradation, such as zinc-
regulated metalloproteases (matrix metalloprotease 2
(MMP2), MMP9, MT1-MMP) [34, 35]. Therefore, we
investigated whether CIP4 KD effects the expression of
MMPs. Immunoblotting revealed a significant reduction
in MMP-2 but not MMP-9 in CIP4 KD cells (Fig. 6f ).
Taken together, these results suggest that CIP4 modu-
lates the kinetics of EGFR signaling and promotes
MMP-2 expression in NPC cells.
CIP4 silencing impairs NPC metastasis in vivo
To evaluate the effects of CIP4 on tumor metastasis in
vivo, the same amount of shRNA-transfected cells (5-8F-
shRNA-CIP4-1, 5-8F-shRNA-CIP4-2) and their control
were injected into nude mice intravenously through the
tail vein. After 6 weeks, the mice were euthanized, and
metastatic lung nodules were counted (Fig. 7a). Al-
though there was no difference in average tumor mass
between CIP4 KD and controls (Fig. 7b), scoring of the
numbers of metastases from hematoxylin and eosin
(H&E)-stained lung tissue sections revealed a significant
reduction in incidence compared with control mice
(Fig. 7c). To extend these findings, we utilized a popliteal
lymph node (LN) metastasis model. The spontaneous
metastasis experiments indicate that the popliteal LN
Fig. 4 CIP4 promotes the EGF-dependent activation of N-WASP in
NPC cells. a 5-8F cells were transfected with control or CIP4-siRNA
and whole-cell lysates were immunoblotted for phospho-N-WASP
(Y256), total N-WASP and CIP4 at 72 h after transfection. Blots were
reprobed for β-actin. b NPC cells transfected with control or
CIP4-siRNA were treated with EGF for 1 min, lysed and probed for
phospho-N-WASp (Y256) and then reprobed for total N-WASp and
CIP4. Blot is representative of three independent experiments. c
densitometric quantification of immunoblot in b
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metastasis rate was significantly reduced from 70% (21/
30) to 20% (6/30) or 26.7% (8/30) via suppression of
CIP4 expression in NPC cells (Fig. 7d). Together these
results corroborate the importance of CIP4 in the regu-
lation of NPC tumor metastasis in vivo.
Discussion
The main obstacle in the current clinical management of
NPC is metastasis [36]. Given its high metastasis rate,
NPC cell motility has been linked to the formation of
different types of cellular membrane protrusions.
Fig. 5 CIP4 plays an important role in invadopodia formation in NPC cells. a and b 5-8F cells and S18 cells transfected with control or CIP4 siRNA
were plated on glass-bottom dishes coated with Gelatin From Pig Skin, Oregon Green® 488 Conjugate and cultured for 20 h before being stained
for endogenous CIP4 and F-actin. The cells were fixed and stained with anti-cortactin antibody (blue) and F-actin (red). The arrowheads indicate
the position of extracellular matrix (ECM)-degrading invadopodia. Scale bar, 30 μm. c and d Gelatin degradation areas were counted and measured,
normalized for cell number and averaged over replicates from three independent experiments. The data are expressed as the mean ± S.D. of three
independent experiments. ***, P < 0.001
Meng et al. Journal of Experimental & Clinical Cancer Research  (2017) 36:21 Page 9 of 13
Fig. 6 (See legend on next page.)
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Lamellipodia extend long distances through the extracel-
lular matrix and pull cell through the tissues. In filo-
podia, actin polymerization directly pushes the
cytomembrane forward [37–39]. Invadopodia deliver
matrix-degrading metalloproteases to clear a path for
cells through the extracellular matrix [40]. Our func-
tional studies confirmed that silencing CIP4, the regula-
tor of invadopodia, impaired MMPs-mediated
degradation of collagen to generate the ECM tracks.
CIP4 is an F-BAR protein that regulates actin-based cell
motility [30]. Roles of CIP4 in cell migration have been
described in neuronal, B lymphoma cells and breast can-
cer [20, 41, 42]. However, we demonstrate the role of
CIP4 in the regulation of invadopodia formation, cell-
migration and cell-ECM degradation during NPC meta-
static events in the present study. We show that inducible
silencing of CIP4 results in defects in EGFR signaling and
impaired motility and invasion of NPC cells. We also
tested the effects of CIP4 silencing on NPC metastasis in
tumor xenograft assays and observed a key role for CIP4
in NPC metastasis. Importantly, our study also profiled
CIP4 expression in human nasopharyngeal carcinoma
patients, which revealed links between high CIP4 levels
and worse prognosis. Together with our findings in NPC
models, these studies identify CIP4 as a key signaling hub
in NPC metastasis.
N-WASP and Cdc42 are critical for the formation of
invadopodia, which are specialized cytoskeletal struc-
tures that combine localized actin protrusion with
matrix metalloproteinases (MMPs) secretion to degrade
extracellular matrices and allow invasion [43, 44]. The
formation of invadopodia requires the activation of the
Cdc42–N-WASP pathway [45]. We found that CIP4 is
fully indispensable in mediating the activation of a
CDC42/N-WASP, a function likely fulfilled by the other
members of the family. Instead, CIP4 is essential for the
formation of invadopodia.
Since the majority of NPCs express high levels of
EGFR, there has been considerable interest in testing
EGFR signaling. Several previous studies have function-
ally linked CIP4 to EGFR trafficking and downstream
signaling to pathways controlling cell motility and inva-
siveness [32, 46]. In the present study, we showed that
silencing CIP4 in NPC cell lines resulted in impaired
EGFR signaling to ERK, whereas high CIP4 expression
promoted activation of the EGFR/ERK/MMP-2 axis in
(See figure on previous page.)
Fig. 6 CIP4 modulates EGFR signaling and promotes MMP-2 expression in NPC cells. a and b Serum-starved 5-8F and S18 Control and KD1 cells
were treated with EGF (100 ng/ml) for 0–20 min. Lysates were subjected to IB with the antibodies indicated on the right. c and d Serum-starved
5-8F and S18 Control and KD1 cells were treated with EGF (100 ng/ml) for 0–120 min. Lysates were subjected to IB with the indicated antibodies.
e Densitometry was performed, and relative phospho-Erk levels are shown in the graph below (mean ± S.D.). *, P < 0.05. f IB analysis of MMP-2
and MMP-9 in 5-8F and S18 Control and KD1 cell lysates. GAPDH was used as a loading control
Fig. 7 CIP4 promotes distant metastasis in vivo. a Histological image of lung metastasis in nude mice after tail vein injection of 5-8F cells. Scale
bar, 500 μm. b The average wet lung weights of the mice were not difference between CIP4 KD and controls. c The numbers of lung metastases
(mean ± S.D.) were counted and summarized. ***P < 0.001. d The metastasis rates of CIP4 knockdown 5-8F cells in vivo. The proportion of popliteal
lymph node metastases was significantly reduced upon CIP4 silencing in 5-8F cells (n = 30 per group). P values were calculated using a chi-square test
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NPC cells. Others have also reported a role for CIP4 in
promoting Src activation and Cadherin switching in
mammary epithelial cells treated with EGF or TGFβ
[32].
Conclusions
In summary, CIP4 plays an important role in the promo-
tion of NPC metastasis by mediating invadopodia forma-
tion and activating the EGFR pathway, which may lead
to the identification of a new therapeutic target for dis-
tant metastasis of NPC.
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